Nanotechnology and Public Interest Dialogue: Some International Observations

This article examines nanotechnology within the context of the public interest. It notes that though nanotechnology research and development investment totalled US$9.6 billion in 2005, the public presently understands neither the implications nor how it might be best governed. The article maps a range of nanotechnology dialogue activities under way within the United Kingdom, the United States, Germany, and Australia. It explores the various approaches to articulating public interest matters and notes a shift in the way in which these governments, on the whole, appear to be attempting to manage nanotechnology “risks.” It argues that open and transparent policy deliberations and extensive public discourse will be pivotal to protecting the public interest, gaining public trust and acceptance of nanotechnologies. The article concludes that though governing emerging technologies in the public interest is not a new concept, nanotechnology does present additional challenges that must be addressed by the guardians of the public interest.

[1]  P. Sandin Dimensions of the Precautionary Principle , 1999, Emerging Technologies: Ethics, Law and Governance.

[2]  Fiona Solomon,et al.  Citizens' Panel on Nanotechnology Report to Participants , 2005 .

[3]  Chris Peterson,et al.  Unbounding the Future: The Nanotechnology Revolution , 1991 .

[4]  Tomasz Twardowski,et al.  Promise, problems and proxies: twenty-five years of debate and regulation in Europe , 2002 .

[5]  G. Hodge,et al.  Introduction: Big Questions for Small Technologies , 2007 .

[6]  R. Pinson Is Nanotechnology Prohibited by the Biological and Chemical Weapons Conventions , 2004 .

[7]  F. Collins,et al.  The Human Genome Project: Lessons from Large-Scale Biology , 2003, Science.

[8]  F. Collins,et al.  New goals for the U.S. Human Genome Project: 1998-2003. , 1998, Science.

[9]  O. Renn,et al.  Nanotechnology and the need for risk governance , 2006, Emerging Technologies: Ethics, Law and Governance.

[10]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[11]  Richard A. L. Jones,et al.  The Social and Economic Challenges of Nanotechnology , 2003 .

[12]  D. Vogel Ships Passing in the Night: The Changing Politics of Risk Regulation in Europe and the United States , 2001 .

[13]  Roland Jackson,et al.  Strengths of Public Dialogue on Science‐related Issues , 2005 .

[14]  Martin W. Bauer,et al.  Biotechnology - the Making of a Global Controversy , 2002 .

[15]  G. Hodge,et al.  Governing nanotechnology: setting the regulatory agenda , 2004 .

[16]  Matthew Kearnes,et al.  Nanotechnology, Governance, and Public Deliberation: What Role for the Social Sciences? , 2005 .

[17]  J A Monteleone Where has all the magic gone? , 1989, Health progress.

[18]  Tanya Sheetz,et al.  Nanotechnology: Awareness and societal concerns , 2005 .

[19]  Jeffrey M. Perkel,et al.  Researchers dissect the mechanisms of HIV infection , 2002 .

[20]  N. Pidgeon,et al.  Reflecting upon the UK's Citizens' Jury on Nanotechnologies: Nano Jury UK , 2006 .

[21]  Jeffery A. Lackney,et al.  The Relationship between Environmental Quality of School Facilities and Student Performance. Energy Smart Schools: Opportunities To Save Money, Save Energy and Improve Student Performance. A Congressional Briefing to the U.S. House of Representatives Committee on Science. , 1997 .

[22]  W. Bainbridge,et al.  Societal implications of nanoscience and nanotechnology , 2001 .

[23]  FROM THE COMMISSION on the precautionary principle , 2022 .

[24]  Roop L. Mahajan,et al.  Contradictory intent? US federal legislation on integrating societal concerns into nanotechnology research and development , 2006 .

[25]  Graeme Hodge,et al.  Nanotechnology: Mapping the wild regulatory frontier , 2006 .

[26]  John Pendergrass,et al.  Project on Emerging Nanotechnologies , 2007 .

[27]  Michael D. Cobb,et al.  Public perceptions about nanotechnology: Risks, benefits and trust , 2004, Emerging Technologies: Ethics, Law and Governance.

[28]  D. Vogel The new politics of risk regulation in Europe , 2001 .

[29]  Ronald Sandler,et al.  The GMO-Nanotech (Dis)Analogy? , 2006 .

[30]  Pao Annual Report, 1994 - 1995 , 1995 .

[31]  Philip Macnaghten,et al.  From Bio to Nano , 2007 .

[32]  M. Roco Nanotechnology: convergence with modern biology and medicine. , 2003, Current opinion in biotechnology.

[33]  M. Adams The precautionary principle and the rhetoric behind it , 2002 .

[34]  D. Av Id,et al.  The Politics of Risk Regulation in Europe and the United States , 2004 .

[35]  D. J. Bennett,et al.  Nanobiotechnology: Responsible Action on Issues in Society and Ethics , 2005 .